The chemopreventive agent phenetyl isothiocyanate sensitizes cells to Fas-mediated apoptosis

Carcinogenesis

Volumn 25, Issue 5, 2004, Pages 765-772

  Pullar, Juliet M ^a   Thomson, Susan J ^a   King, Monica J ^a   Turnbull, Christopher I ^a   Midwinter, Robyn G ^a   Hampton, Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTINEOPLASTIC AGENT; BUTHIONINE SULFOXIMINE; CASPASE 3; CELL PROTEIN; CELL RECEPTOR; FAS ANTIBODY; FAS ANTIGEN; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENETHYL ISOTHIOCYANATE; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; THIOL; UO 126; ALDEHYDE DEHYDROGENASE; CASP3 PROTEIN, HUMAN; CASPASE; ISOTHIOCYANIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4;

APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LETHAL DOSE; LEUKEMIA CELL LINE; MOLECULAR MIMICRY; PRIORITY JOURNAL; PROTEIN MODIFICATION; SENSITIZATION; BLADDER TUMOR; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ALDEHYDE DEHYDROGENASE; ANTICARCINOGENIC AGENTS; ANTIGENS, CD95; APOPTOSIS; BUTHIONINE SULFOXIMINE; CASPASE 3; CASPASES; CHEMOPREVENTION; DRUG RESISTANCE, NEOPLASM; HUMANS; ISOTHIOCYANATES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 2442526626     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh063     Document Type: Article

References (51)

1. Krammer,P.H. (2000) CD95's deadly mission in the immune system. Nature, 407, 789-795.
2. Siegel,R.M., Chan,F.K., Chun,H.J. and Lenardo,M.J. (2000) The multi-faceted role of Fas signaling in immune cell homeostasis and auto-immunity. Nature Immunol., 1, 469-474.
3. O'Flaherty,E., Wong,W.K., Pettit,S.J., Seymour,K., Ali,S. and Kirby,J.A. (2000) Regulation of T-cell apoptosis: a mixed lymphocyte reaction model. Immunology, 100, 289-299.
4. Jenkins,M., Keir,M. and McCune,J.M. (1999) Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal. J. Immunol., 163, 1195-1204.
5. Willems,F., Amraoui,Z., Vanderheyde,N., Verhasselt,V., Aksoy,E., Scaffidi,C., Peter,M.E., Krammer,P.H. and Goldman,M. (2000) Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood, 95, 3478-3482.
6. Mori,S., Murakami-Mori,K., Jewett,A., Nakamura,S. and Bonavida,B. (1996) Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res., 56, 1874-1879.
7. Natoli,G., Ianni,A., Costanzo,A., De Petrillo,G., Ilari,I., Chirillo,P., Balsano,C. and Levrero,M. (1995) Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene, 11, 1157-1164.
8. Owen-Schaub,L.B., Radinsky,R., Kruzel,E., Berry,K. and Yonehara,S. (1994) Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res., 54, 1580-1586.
9. Shima,Y., Nishimoto,N., Ogata,A., Fujii,Y., Yoshizaki,K. and Kishimoto,T. (1995) Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis. Blood, 85, 757-764.
10. Hueber,A.O., Zornig,M., Lyon,D., Suda,T., Nagata,S. and Evan,G.I. (1997) Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science, 278, 1305-1309.
11. Micheau,O., Solary,E., Hammann,A. and Dimanche-Boitrel,M.T. (1999) Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem., 274, 7987-7992.
12. Krammer,P.H. (1997) The tumor strikes back: new data on expression of the CD95 (APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology. Cell Death Diff., 4, 362-364.
13. Adams,J.M. and Cory,S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-1326.
14. Midis,G.P., Shen,Y. and Owen-Schaub,L.B. (1996) Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res., 56, 3870-3874.
15. Poulaki,V., Mitsiades,N., Romero,M.E. and Tsokos,M. (2001) Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2. Cancer Res., 61, 4864-4872.
16. Zhang,Y. and Talalay,P. (1994) Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res., 54, 1976s-1981s.
17. Hecht,S.S. (1999) Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J. Nutr., 129, 768S-774S.
18. Yang,Y.M., Conaway,C.C., Chiao,J.W., Wang,C.X., Amin,S., Whysner,J., Dai,W., Reinhardt,J. and Chung,F.L. (2002) Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res., 62, 2-7.
19. Chen,Y.R., Wang,W., Kong,A.N. and Tan,T.H. (1998) Molecular mechanisms of c-Jun N-terminal kinase-mediated apoptosis induced by anticarcinogenic isothiocyanates. J. Biol. Chem., 273, 1769-1775.
20. Yu,R., Mandlekar,S., Harvey,K.J., Ucker,D.S. and Kong,A.N. (1998) Chemopreventive isothiocyanates induce apoptosis and caspase-3-like protease activity. Cancer Res., 58, 402-408.
21. Yu,R., Jiao,J.J., Duh,J.L., Tan,T.H. and Kong,A.N. (1996) Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Cancer Res., 56, 2954-2959.
22. Xu,K. and Thornalley,P.J. (2001) Involvement of glutathione metabolism in the cytotoxicity of the phenethyl isothiocyanate and its cysteine conjugate to human leukaemia cells in vitro. Biochem. Pharmacol., 61, 165-177.
23. Meister,A. (1994) Glutathione, ascorbate and cellular protection. Cancer Res., 54, 1969s-1975s.
24. Li,N. and Oberley,T.D. (1998) Modulation of antioxidant enzymes, reactive oxygen species and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle. J. Cell Physiol., 177, 148-160.
25. Schafer,F.Q. and Buettner,G.R. (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med., 30, 1191-1212.
26. Cotgreave,I.A. and Gerdes,R.G. (1998) Recent trends in glutathione biochemistry - glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem. Biophys. Res. Commun., 242, 1-9.
27. Deas,O., Dumont,C., Mollereau,B., Metivier,D., Pasquier,C., Bernard-Pomier,G., Hirsch,F., Charpentier,B. and Senik,A. (1997) Thiol-mediated inhibition of FAS and CD2 apoptotic signaling in activated human peripheral T cells. Int. Immunol., 9, 117-125.
28. Watson,R.W., Rotstein,O.D., Jimenez,M., Parodo,J. and Marshall,J.C. (1997) Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils. Blood, 89, 4175-4181.
29. Chiba,T., Takahashi,S., Sato,N., Ishii,S. and Kikuchi,K. (1996) Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells. Eur. J. Immunol., 26, 1164-1169.
30. Kohno,T., Yamada,Y., Hata,T., Mori,H., Yamamura,M., Tomonaga,M., Urata,Y., Goto,S. and Kondo,T. (1996) Relation of oxidative stress and glutathione synthesis to CD95 (Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. J. Immunol., 156, 4722-4728.
31. Iwata,S., Hori,T., Sato,N., Hirota,K., Sasada,T., Mitsui,A., Hirakawa,T. and Yodoi,J. (1997) Adult T cell leukemia (ATL)-derived factor/human thioredoxin prevents apoptosis of lymphoid cells induced by L-cystine and glutathione depletion. J. Immunol., 158, 3108-3117.
32. Powis,G., Mustacich,D. and Coon,A. (2000) The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med., 29, 312-322.
33. van den Dobbelsteen,D.J., Nobel,C.S., Schlegel,J., Cotgreave,I.A., Orrenius,S. and Slater,A.F. (1996) Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J. Biol. Chem., 271, 15420-15427.
34. Ghibelli,L., Fanelli,C., Rotilio,G., Lafavia,E., Coppola,S., Colussi,C., Civitareale,P. and Ciriolo,M.R. (1998) Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J., 12, 479-486.
35. Clement,M.V. and Stamenkovic,I. (1996) Superoxide anion is a natural inhibitor of Fas-mediated cell death. EMBO J., 15, 216-225.
36. Pullar,J.M. and Hampton,M.B. (2002) Diphenyleneiodonium triggers the efflux of glutathione from cultured cells. J. Biol. Chem., 277, 19402-19407.
37. Nicholson,D.W., Ali,A., Thornberry,N.A., Vaillancourt,J.P., Ding,C.K., Gallant,M., Gareau,Y., Griffin,P.R., Labelle,M. and Lazebnik,Y.A. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
38. Martin,J. and White,I.N.H. (t991) Fluorimetric determination of oxidised and reduced glutathione in cells and tissues by high-performance liquid chromatography following derivatisation with dansyl chloride. J. Chromatogr., 568, 219-225.
39. Cotgreave,I.A. and Moldeus,P. (1986) Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems. J. Biochem. Biophys. Methods, 13, 231-249.
40. Zhang,Y. (2000) Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis, 21, 1175-1182.
41. Zhang,Y., Talalay,P., Cho,C.G. and Posner,G.H. (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl Acad. Sci. USA, 89, 2399-2403.
42. Greil,R., Anether,G., Johrer,K. and Tinhofer,I. (2003) Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets and therapeutic tools. J. Leukoc. Biol., 74, 311-330.
43. Yu,R., Lei,W., Mandlekar,S., Weber,M.J., Der,C.J., Wu,J. and Kong,A.T. (1999) Role of a mitogen-activated protein kinase pathway in the induction of phase II detoxifying enzymes by chemicals. J. Biol. Chem., 274, 27545-27552.
44. Xu,K. and Thornalley,P.J. (2000) Signal transduction activated by the cancer chemopreventive isothiocyanates: cleavage of BID protein, tyrosine phosphorylation and activation of JNK. Br. J. Cancer, 84, 1-4.
45. Xiao,D. and Singh,S.V. (2002) Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res., 62, 3615-3619.
46. Finkel,T. (2000) Redox-dependent signal transduction. FEBS Lett., 476, 52-54.
47. Hampton,M.B., Stamenkovic,I. and Winterbourn,C.C. (2002) Interaction with substrate sensitises caspase-3 to inactivation by hydrogen peroxide. FEBS Lett., 517, 229-232.
48. Saitoh,M., Nishitoh,H., Fujii,M., Takeda,K., Tobiume,K., Sawada,Y., Kawabata,M., Miyazono,K. and Ichijo,H. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J., 17, 2596-2606.
49. McStay,G.P., Clarke,S.J. and Halestrap,A.P. (2002) Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem. J., 367, 541-548.
50. Dinkova-Kostova,A.T., Holtzclaw,W.D., Cole,R.N., Itoh,K., Wakabayashi,N., Katoh,Y., Yamamoto,M. and Talalay,P. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl Acad. Sci. USA, 99, 11908-11913.
51. Cory,S. and Adams,J.M. (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nature Rev. Cancer, 2, 647-656.